Medtronic tests third cervical disc in US trial
This article was originally published in Clinica
Executive Summary
As part of its efforts to enter the as-yet-untapped US market for artificial cervical discs, Medtronic has begun enrolling patients into an FDA-approved trial of its Prestige LP implant. Also in its spinal business, the firm has received European market approval to use its bone growth protein product, InductOs, in lumbar spine fusions.